in

mRNA trial shows promise for these therapies to revolutionise medicine

SEI 157342562


An illustration of messenger ribonucleic acid (mRNA)

Kateryna Kon/Science Photo Library/Getty Images

Sixteen people have benefited from an experimental mRNA therapy that replaces a faulty enzyme behind a rare inherited condition, the biotech company Moderna announced on 19 May. This is great…

Written by bourbiza

Bourbiza Mohamed is an award-winning travel journalist who has been writing about her adventures around the world for over a decade. With a passion for exploring new cultures and experiencing different ways of life, Bourbiza Mohamed has traveled to over 107 countries across six continents and has documented her journeys in numerous publications.

Bourbiza Mohamed writing is known for its vivid descriptions and personal anecdotes, which transport readers to the destinations she writes about. Her articles cover a wide range of topics, from off-the-beaten-path adventures to luxury travel experiences, and she has a particular interest in sustainable tourism and responsible travel.

In addition to her writing, Bourbiza Mohamed is also an accomplished photographer, capturing stunning images of the people, landscapes, and wildlife she encounters on her travels. Her photos have been featured in publications such as National Geographic, Lonely Planet, and Conde Nast Traveler.

stem rust 01

Fungal Infections Could Obliterate Our Food Supply, Scientists Warn : ScienceAlert

CE84EB14 D479 4226 B66E5E8770983525

Social Media Can Harm Kids. Could New Regulations Help?